Lupin launches generic Diovan tabs
Is indicated for the treatment of hypertension and heart failure
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Drug and Cosmetics (Amendment) Bill, 2015 to be introduced in Budget Session
Industry hails the move
Jubilant Life Sciences receives US FDA nod for Mycophenolate and MofetilRizatriptan tablets
Mycophenolate Mofetil is an immunosuppressant to help prevent organ rejection in transplants and Rizatriptan is used for the…
RPG Life Sciences appoints C T Renganathan as its MD
RPG Life Sciences has appointed CT Renganathan as its Managing Director and an Additional Director for a term of three years with…
Novartis completes divestment of animal health biz to Eli Lilly for $5.4 billion
The completion of this transaction will focus Novartis on its three leading businesses of global scale: innovative…
COMSOL Server launched, available to run simulation apps
With COMSOL Server, applications can now be distributed throughout an organisation, providing design teams, production…
Ministry of Commerce & Industry invites comments on first draft of National IPR Policy
The Ministry of Commerce & Industry has invited comments form all stakeholders on the first draft of the National IPR Policy.…
Lupin receives approval for generic prezista tabs
Lupin has received tentative approval for its darunavir ethanolate tablets 75 mg, 150 mg, 300 mg, 400 mg, 600 mg and 800 mg from…
Suven Life secures three product patents in Eurasia, Japan and Mexico
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven
Foreign pharma cos won 77 per cent of all patents in last 10 years
The large portion of patents going to foreign companies clearly indicates that the Indian patent regime is non-discriminatory and…
Lupin receives US FDA approval for Epivir tabs
Would commence marketing the product shortly
Novartis’ Cosentyx gets Japanese approval for psoriasis, psoriatic arthritis
First interleukin-17A inhibitor to get Japanese nod for either indication
Torrent Pharma in agreement with Reliance Life Sciences
Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a period of…
1st draft of national IPR policy released
The Department of Industrial Policy and Promotion (DIPP) has published the first draft of the national IPR policy yesterday. Dated…
Dr Reddy’s, IPCA Labs products come under Canada govt scanner
Health Canada, the North American country’s food and drug regulator, has asked Canadian importers to quarantine health products…
Med devices gets 100% FDI
Industry hails move; asks for more changes to "pro imports" policies
CCI approves multi-billion dollar deal between GlaxoSmithKline and Novartis
It involves acquisition of GSK's portfolio of oncology products by Novartis for $16 billion
National conference on ‘Drug Discovery and Drug Targeting in Metabolic Diseases’…
Around 120 participants took part in the event
Clinical research in 2015: The ghost of Christmas past, present and yet to come
Clinical research in India has gone through Dickensian times in the past two years. Alishan Naqvee, Partner and Abhijeet Das,…
Cipla bags Rs 1,100 cr order for HIV drugs from South Africa
The medication will be produced at the company's 23,000 square meter manufacturing site in Kwazulu-Natal